230 related articles for article (PubMed ID: 21674557)
1. Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
Mazzocca A; Dituri F; Lupo L; Quaranta M; Antonaci S; Giannelli G
Hepatology; 2011 Sep; 54(3):920-30. PubMed ID: 21674557
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of head and neck cancer-derived peritumoral and cancer-associated fibroblasts.
Zhou J; Schwenk-Zieger S; Kranz G; Walz C; Klauschen F; Dhawan S; Canis M; Gires O; Haubner F; Baumeister P; Kohlbauer V
Front Oncol; 2022; 12():984138. PubMed ID: 36544698
[TBL] [Abstract][Full Text] [Related]
4. The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis.
Sukowati CH; Anfuso B; Crocé LS; Tiribelli C
BMC Cancer; 2015 Mar; 15():188. PubMed ID: 25879842
[TBL] [Abstract][Full Text] [Related]
5. Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.
Qu C; He L; Yao N; Li J; Jiang Y; Li B; Peng S; Hu K; Chen D; Chen G; Huang W; Cao M; Fan J; Yuan Y; Ye W; Hong J
Hepatology; 2021 Jul; 74(1):458-473. PubMed ID: 33609283
[TBL] [Abstract][Full Text] [Related]
6. Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels.
Enooku K; Uranbileg B; Ikeda H; Kurano M; Sato M; Kudo H; Maki H; Koike K; Hasegawa K; Kokudo N; Yatomi Y
PLoS One; 2016; 11(9):e0161825. PubMed ID: 27583415
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-145 in cardiac myofibroblast differentiation.
Wang YS; Li SH; Guo J; Mihic A; Wu J; Sun L; Davis K; Weisel RD; Li RK
J Mol Cell Cardiol; 2014 Jan; 66():94-105. PubMed ID: 24001939
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells.
Lin ZY; Chuang YH; Chuang WL
Biomed Pharmacother; 2012 Oct; 66(7):525-9. PubMed ID: 22739041
[TBL] [Abstract][Full Text] [Related]
9. Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma.
Yang XY; Zhang D; Zou QF; Fan F; Shen F
Med Oncol; 2013; 30(3):593. PubMed ID: 23794251
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH
J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.
Hanley CJ; Mellone M; Ford K; Thirdborough SM; Mellows T; Frampton SJ; Smith DM; Harden E; Szyndralewiez C; Bullock M; Noble F; Moutasim KA; King EV; Vijayanand P; Mirnezami AH; Underwood TJ; Ottensmeier CH; Thomas GJ
J Natl Cancer Inst; 2018 Jan; 110(1):109-20. PubMed ID: 28922779
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.
Lou L; Chen YX; Jin L; Li X; Tao X; Zhu J; Chen X; Wu S; Ye W; He J; Ding G
J Int Med Res; 2013 Feb; 41(1):55-63. PubMed ID: 23569130
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma cells remodel the pro-metastatic tumour microenvironment through recruitment and activation of fibroblasts via paracrine Egfl7 signaling.
Sun B; Lei X; Cao M; Li Y; Yang LY
Cell Commun Signal; 2023 Jul; 21(1):180. PubMed ID: 37480091
[TBL] [Abstract][Full Text] [Related]
15. Peri-tumor fibroblasts promote tumorigenesis and metastasis of hepatocellular carcinoma via Interleukin6/STAT3 signaling pathway.
Zhao Z; Xiong S; Wang R; Li Y; Wang X; Wang Y; Bai S; Chen W; Zhao Y; Cheng B
Cancer Manag Res; 2019; 11():2889-2901. PubMed ID: 31118769
[No Abstract] [Full Text] [Related]
16. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Cho M; Suh DS; Yoon MS; Chang CL; Jung JS; Kim JH
Stem Cells; 2008 Mar; 26(3):789-97. PubMed ID: 18065393
[TBL] [Abstract][Full Text] [Related]
17. Plasma lysophosphatidic acid levels and hepatocellular carcinoma.
Ikeda H; Enooku K; Ohkawa R; Koike K; Yatomi Y
Hepatology; 2013 Jan; 57(1):417-8. PubMed ID: 22707340
[No Abstract] [Full Text] [Related]
18. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
Park SY; Jeong KJ; Panupinthu N; Yu S; Lee J; Han JW; Kim JM; Lee JS; Kang J; Park CG; Mills GB; Lee HY
Oncogene; 2011 Mar; 30(11):1351-9. PubMed ID: 21102517
[TBL] [Abstract][Full Text] [Related]
19. [Transdifferentiation of fibroblasts into myofibroblasts in the skin lesion of systemic sclerosis: role of transforming growth factor β1 and its signal transduction].
Liu T; Hu XD
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1840-5. PubMed ID: 22126761
[TBL] [Abstract][Full Text] [Related]
20. Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study.
Faouzi S; Le Bail B; Neaud V; Boussarie L; Saric J; Bioulac-Sage P; Balabaud C; Rosenbaum J
J Hepatol; 1999 Feb; 30(2):275-84. PubMed ID: 10068108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
